MBX Biosciences Inc (NASDAQ: MBX) kicked off On Friday, up 3.77% from the previous trading day, before settling in for the closing price of $13.25. Over the past 52 weeks, MBX has traded in a range of $4.81-$27.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 51.90%. With a float of $14.85 million, this company’s outstanding shares have now reached $33.42 million.
Considering the fact that the conglomerate employs 43 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
MBX Biosciences Inc (MBX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of MBX Biosciences Inc is 55.58%, while institutional ownership is 54.29%. The most recent insider transaction that took place on Apr 08 ’25, was worth 45,312. In this transaction Director of this company bought 7,693 shares at a rate of $5.89, taking the stock ownership to the 24,329 shares. Before that another transaction happened on Feb 18 ’25, when Company’s Director bought 143,170 for $10.84, making the entire transaction worth $1,551,963. This insider now owns 3,255,000 shares in total.
MBX Biosciences Inc (MBX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 51.90% per share during the next fiscal year.
MBX Biosciences Inc (NASDAQ: MBX) Trading Performance Indicators
Take a look at MBX Biosciences Inc’s (MBX) current performance indicators. Last quarter, stock had a quick ratio of 23.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.20, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -2.90 in one year’s time.
Technical Analysis of MBX Biosciences Inc (MBX)
Compared to the last year’s volume of 0.32 million, its volume of 0.64 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 58.83%.
During the past 100 days, MBX Biosciences Inc’s (MBX) raw stochastic average was set at 80.33%, which indicates a significant increase from 50.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.72 in the past 14 days, which was higher than the 1.08 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.29, while its 200-day Moving Average is $13.60. Nevertheless, the first resistance level for the watch stands at $14.26 in the near term. At $14.78, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.63. If the price goes on to break the first support level at $12.89, it is likely to go to the next support level at $12.04. Should the price break the second support level, the third support level stands at $11.52.
MBX Biosciences Inc (NASDAQ: MBX) Key Stats
The company with the Market Capitalisation of 459.59 million has total of 33,424K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -61,920 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -23,880 K.
